- Home
- ENSC vs MTNB Comparison
ENSC vs MTNB Comparison
Compare ENSC & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- MTNB
- Stock Information
- Founded
- ENSC 2003
- MTNB 2013
- Country
- ENSC United States
- MTNB United States
- Employees
- ENSC N/A
- MTNB N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- ENSC Health Care
- MTNB Health Care
- Exchange
- ENSC Nasdaq
- MTNB Nasdaq
- Market Cap
- ENSC 2.9M
- MTNB 3.1M
- IPO Year
- ENSC N/A
- MTNB N/A
- Fundamental
- Price
- ENSC $3.29
- MTNB $0.67
- Analyst Decision
- ENSC
- MTNB Hold
- Analyst Count
- ENSC 0
- MTNB 1
- Target Price
- ENSC N/A
- MTNB N/A
- AVG Volume (30 Days)
- ENSC 4.9M
- MTNB 32.8K
- Earning Date
- ENSC 05-12-2025
- MTNB 04-15-2025
- Dividend Yield
- ENSC N/A
- MTNB N/A
- EPS Growth
- ENSC N/A
- MTNB N/A
- EPS
- ENSC N/A
- MTNB N/A
- Revenue
- ENSC $5,210,031.00
- MTNB N/A
- Revenue This Year
- ENSC N/A
- MTNB N/A
- Revenue Next Year
- ENSC N/A
- MTNB N/A
- P/E Ratio
- ENSC N/A
- MTNB N/A
- Revenue Growth
- ENSC 133.58
- MTNB N/A
- 52 Week Low
- ENSC $1.62
- MTNB $0.48
- 52 Week High
- ENSC $14.67
- MTNB $9.70
- Technical
- Relative Strength Index (RSI)
- ENSC 55.92
- MTNB 64.44
- Support Level
- ENSC $3.02
- MTNB $0.54
- Resistance Level
- ENSC $4.85
- MTNB $0.60
- Average True Range (ATR)
- ENSC 0.40
- MTNB 0.05
- MACD
- ENSC 0.27
- MTNB 0.01
- Stochastic Oscillator
- ENSC 51.70
- MTNB 100.00
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.